
Torii Pharmaceutical Co Ltd
TSE:4551

Torii Pharmaceutical Co Ltd
Cash Interest Paid
Torii Pharmaceutical Co Ltd
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Torii Pharmaceutical Co Ltd
TSE:4551
|
Cash Interest Paid
ÂĄ0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash Interest Paid
ÂĄ99.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
34%
|
|
![]() |
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash Interest Paid
ÂĄ1.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
![]() |
Otsuka Holdings Co Ltd
TSE:4578
|
Cash Interest Paid
ÂĄ6.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
![]() |
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash Interest Paid
ÂĄ87m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Astellas Pharma Inc
TSE:4503
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Torii Pharmaceutical Co Ltd
Glance View
Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

See Also
What is Torii Pharmaceutical Co Ltd's Cash Interest Paid?
Cash Interest Paid
0
JPY
Based on the financial report for Dec 31, 2024, Torii Pharmaceutical Co Ltd's Cash Interest Paid amounts to 0 JPY.